{"id":"W2937111213","doi":"10.1016/j.jcjd.2019.04.004","title":"CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); University of Waterloo; McGill University Health Centre; University of British Columbia; Diabetes Canada; University of Toronto; University of Manitoba","funders":"Janssen Pharmaceuticals; Janssen Research and Development; Takeda Canada; Mitsubishi Tanabe Pharma Corporation; Novo Nordisk; Valeant Pharmaceuticals International; Novartis; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer; Sanofi; Merck; Janssen Biotech; American Diabetes Association; Abbott Laboratories; Boehringer Ingelheim","keywords":"Canagliflozin; Medicine; Clinical Practice; Diabetes mellitus; Type 2 Diabetes Mellitus; Family medicine; Pediatrics; Intensive care medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001632401,0.0004410233,0.001025516,0.002149543,0.001181623,0.001435118,0.001527657,0.0007769638,0.003976912],"category_scores_gemma":[0.008685703,0.0003628202,0.0007043871,0.008999613,0.000363903,0.0006375114,0.0008659922,0.001178097,0.0005018524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02108197,"about_ca_system_score_gemma":0.04054435,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9736251,"about_ca_topic_score_gemma":0.9782955,"domain_scores_codex":[0.9972364,0.0001981723,0.0002382394,0.0004120724,0.001444034,0.00047109],"domain_scores_gemma":[0.9912947,0.0005372437,0.002310856,0.0002375521,0.004207749,0.00141195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00101357,0.0001408646,0.9060278,0.0005155077,0.0005155038,0.0001305477,0.0002583988,0.0003950132,0.0001294592,0.0005565346,0.07133193,0.01898495],"study_design_scores_gemma":[0.0002602547,0.00005416522,0.9910561,0.0001603984,0.0002203206,0.0001069752,0.0002060755,0.000574003,0.00007749491,0.00006656598,0.007177786,0.00003983914],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6522495,0.009672359,0.0008084071,0.005999953,0.0002762797,0.0006104155,0.3036394,0.0002715268,0.0264721],"genre_scores_gemma":[0.9086426,0.004294072,0.001504736,0.001468381,0.0001293702,0.0003220849,0.08131476,0.00005228594,0.002271769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02637488,"threshold_uncertainty_score":0.1529611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02065327200253389,"score_gpt":0.2895179706560487,"score_spread":0.2688646986535149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}